Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone

February 5, 2024 updated by: Pei-Hung Liao

Identifying the Risk of Lung Cancer Linked to Environmental Hormones

To apply machine learning to construct an association model regarding lung cancer and environmental hormones to more comprehensively identify factors that may lead to lung cancer and to improve existing lung cancer nursing assessments.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

The present study is exploratory, and its design was divided into three stages: Stage 1 explored the environmental hormonal risk factors for lung cancer and constructed an association model using machine learning algorithms. Stage 2 validated the results of the association model with better predictive results in clinical settings. Stage 3 involved recommendations for reconstructing nursing assessments based on the results of the clinical model validation. The three stages are summarized as follows.

Study Type

Observational

Enrollment (Estimated)

128

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • National Taipei University of Nursing and Health Science
      • Taipei, Taiwan
        • National Taiwan University, Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study focused on lung cancer cases and investigated the association with exposure to environmental hormones

Description

Inclusion Criteria:

  1. 20 years or older;
  2. conscious, without mental disorders;
  3. able to use Mandarin to communicate, had a smartphone or tablet computer and could operate it by themselves,
  4. and were willing to participate in the study after the reasons for participation were explained and a consent form was signed, indicating their consent.

Exclusion Criteria:

  • The exclusion criteria were those who could not understand the content of the nursing assessment questions and those with mental disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
identify factors that may lead to lung cancer and environmental hormones.
Time Frame: the database research samples from May 2014 to December 2020.
This association model can assist in identifying the risk groups of lung cancer and advising physicians on the appropriate environmental hormone testing and treatment to provide nursing guidance and medical advice
the database research samples from May 2014 to December 2020.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

January 20, 2024

First Submitted That Met QC Criteria

February 5, 2024

First Posted (Estimated)

February 14, 2024

Study Record Updates

Last Update Posted (Estimated)

February 14, 2024

Last Update Submitted That Met QC Criteria

February 5, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Neoplasms

Subscribe